This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use

BioCap 2018; In Conversation with Geoff Davison 13 August 2018

Welcome to my BioCap Conference blog. The Bionow team are really looking forward to welcoming you to BioCap 2018 at Alderley Park on the 27th September, we have been working hard on an expansive and exciting programme, and it promises to be a day well spent for all.

> Read More

Blueberry Therapeutics Limited closes £10m funding to support development of nanomedicines portfolio 14 August 2018

Blueberry Therapeutics Limited, (“Blueberry Therapeutics”) a drug discovery and development company focused on developing innovative nanomedicines for difficult to treat skin and nail infections, today announces that it has successfully completed its £10m Series B Fundraising with investment from China Medical Venture Investment (HK) Limited, a wholly owned subsidiary of China Medical System Holdings Limited (“CMS”), and A&B (HK) Company Limited (“A&B”).

> Read More

Nexus Labs announces seed funding from Catapult Ventures and BioCity to launch 8 August 2018

Nexus Labs, a pioneering medical education startup, today announced the completion of a Seed funding round to launch its first product, a digital platform aimed at enhancing the learning experience of students and doctors around the world. The funding came from the GM&C Life Sciences Fund, managed by Catapult Ventures; and Alderley Park Ventures, managed by BioCity.

> Read More